DongKook Pharmaceutical Co., Ltd. (086450.KQ)

KRW 16350.0

(-1.57%)

Annual Cash Flows

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Operating Cash Flow 43.57 Billion 49.15 Billion 44.24 Billion 59.67 Billion 69.39 Billion 34.69 Billion
Net Income 47.17 Billion 52.89 Billion 50.34 Billion 55.92 Billion 56.31 Billion 46.94 Billion
Depreciation & Amortization 21.08 Billion 19.17 Billion 17.34 Billion 15.1 Billion 13.6 Billion 9.08 Billion
Deferred income taxes - 28.98 Billion 21.11 Billion 34.93 Billion - -
Stock-based compensation -162.46 Million -297.31 Million -24.01 Million 673.62 Million - -
Change in working capital -35.16 Billion -39.03 Billion -22.27 Billion -28.56 Billion -9.78 Billion -21.53 Billion
Other non-cash items 70.55 Billion 81.18 Billion 58.52 Billion 75.75 Billion 39.03 Billion 35.86 Billion
Investing Cash Flow -57.09 Billion -20.75 Billion -45.82 Billion -99.64 Billion -57.75 Billion -92.55 Billion
Investments in PPE -39.35 Billion -51.22 Billion -51.42 Billion -41.39 Billion -25.18 Billion -75.82 Billion
Acquisitions 3.57 Billion 25.35 Million -12.98 Billion 29.4 Million 146.78 Million 581.95 Million
Investment purchases -155.61 Billion -261.68 Billion -216.19 Billion -171.23 Billion -107.47 Billion -21.07 Billion
Sales/Maturities of investments 134.24 Billion 292.78 Billion 232.85 Billion 121.88 Billion 73.31 Billion 2.7 Billion
Other Investing Activities 48.98 Million -642.52 Million 1.92 Billion -8.92 Billion 1.44 Billion 1.05 Billion
Financing Cash Flow 623.23 Million -38.89 Billion 32.43 Billion 25.09 Billion -2.91 Billion 56.43 Billion
Debt repayment -10.75 Billion -30.16 Billion -42.33 Billion -34.62 Billion -639.01 Million -45.42 Billion
Dividends payments -8.05 Billion -8.04 Billion -8.04 Billion -7.15 Billion -4.65 Billion -4.57 Billion
Common Stock Repurchased -2.52 Billion - - - -438.00 -
Common Stock Issuance 107.31 Million - - - 1.59 Billion 12.4 Billion
Other Financing Activities 449.04 Million 1.57 Billion 1.26 Billion 323.98 Million 784.11 Million 3.18 Billion
Accounts receivables -27.64 Billion -13.29 Billion 1.09 Billion -18.88 Billion -1 Billion -5.39 Billion
Accounts payables 28.95 Billion 4.6 Billion -1.34 Billion 7.84 Billion -2.36 Billion -2.2 Billion
Inventory -19.22 Billion -18.01 Billion -24.74 Billion -17.29 Billion 802.04 Million -9.88 Billion
Other working capital -17.25 Billion -12.32 Billion 2.72 Billion -230.77 Million -7.21 Billion -4.05 Billion
Cash at beginning of period 73.69 Billion 85.44 Billion 54.53 Billion 70.26 Billion 61.8 Billion 67 Billion
Cash at end of period 60.55 Billion 73.69 Billion 85.44 Billion 54.53 Billion 70.26 Billion 61.8 Billion
Capital Expenditure -39.35 Billion -51.22 Billion -51.42 Billion -41.39 Billion -25.18 Billion -75.82 Billion
Effect of forex changes on cash -245.53 Million -459.6 Million 50.51 Million -849.81 Million -270.52 Million 90.13 Million
Net cash flow / Change in cash -13.14 Billion -11.75 Billion 30.9 Billion -15.72 Billion 8.45 Billion -5.2 Billion
Free Cash Flow 4.22 Billion -2.07 Billion -7.17 Billion 18.28 Billion 44.2 Billion -41.12 Billion

Cash Flow Charts